trực tiếp đá gà hôm nay


trực tiếp đá gà hôm nayLiên kết đăng nhập
CY;Cyclophosphamid;ASTA;Neosar;Endoxan;Cyclophosphamide CRS;(Bis(chloro-2-ethyl)amino)-2-tetrahydro-3,4,5,6-oxazaphosphorine-1,3,2-oxide-2 hydrate;B 518;Clafen;CB 4564
MOL File:
MSDS File:

シクロホスファミド 物理性質

融点 :
沸点 :
336.1±52.0 °C(Predicted)
比重(密度) :
1.33±0.1 g/cm3(Predicted)
貯蔵温度 :
Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
≥11.85 mg/mL in H2O with gentle warming and ultrasonic; ≥13.05 mg/mL in DMSO; ≥50.8 mg/mL in EtOH
外見 :
水消融度 :
溶ける。 23℃で1~5g/100mL
BCS Class:
CAS データベース:
50-18-0(CAS DataBase Reference)
1 (Vol. 26, Sup 7, 100A) 2012
  • リスクと宁静性に関する申明
  • 危険无害脾气報のコード(GHS)
Sフレーズ  22-24/25
国連危険物分類  6.1(b)
容器等級  III
毒性 LD50 oral in rat: 100mg/kg
絵表现(GHS) trực tiếp đá gà hôm nayLiên kết đăng nhậptrực tiếp đá gà hôm nayLiên kết đăng nhập
コード 危険无害脾气報 危険无害性クラス 辨别 注重喚起語 シンボル P コード
H301 飲み込むと有毒 急性毒性、経口 3 危険 trực tiếp đá gà hôm nayLiên kết đăng nhập P264, P270, P301+P310, P321, P330,P405, P501
H340 遺伝性疾患のおそれ 生殖細胞変異原性 1A, 1B 危険 trực tiếp đá gà hôm nayLiên kết đăng nhập
H350 発がんのおそれ 発がん性 1A, 1B 危険 trực tiếp đá gà hôm nayLiên kết đăng nhập
H360 生殖能または胎児への悪影響のおそれ 生殖毒性 1A, 1B 危険 trực tiếp đá gà hôm nayLiên kết đăng nhập
P264 取扱い後は皮膚をよく洗うこと。
P264 取扱い後は手や顔をよく洗うこと。
P270 この製品を利用する時に、飲食または喫煙をしないこ と。
P301+P310 飲み込んだ場合:直ちに医師に連絡すること。
P321 特別な処置が须要である(このラベルの... を見よ)。
P330 口をすすぐこと。
P405 施錠して保存すること。
P501 内容物/容器を...に廃棄すること。

シクロホスファミド 価格 もっと(1)

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入
富士フイルム和光純薬股份有限公司(wako) W01TOC4091
50-18-0 50mg ¥25000 2025-03-01 購入

シクロホスファミド MSDS


シクロホスファミド 化学特征,用处語,生産方式


シクロホスファミド,ビス(2-クロロエチル)アミンにオキシ塩化リンを反応させ,次に2-アミノプロパン-1-オールと環化させると得られる.ラセミ体は無色の柱状晶.融点51~52 ℃.一水和物は融点41 ℃.(R)-シクロホスファミドは融点65~66 ℃,[α]20D +2.3°(メタノール).酢酸に易溶,エタノール,ベンゼン,水に可溶.多発性骨髄腫,悪性リンパ腫,乳がん,急性白血病,肺がん治療薬として利用される.LD50 421 mg/kg(マウス,静注).シクロホスファミド,ナイトロジェン・マスタード誘導体の一種。核酸やその他の細胞構成成份をアルキル化して細胞の代謝を阻害し,特に腫瘍細胞を死にいたらしめる。こうした感化をもつ抗腫瘍剤をアルキル化剤と呼んでいる。それ自体に抗腫瘍性はなく,生体内で開環されて活性物質となる。腫瘍細胞に対する選択性は高い。宁静域は高く,急性毒性はナイトロジェンマスタード-N-オキシドの約2分の1で,慢性毒性もアルキル化剤のなかでは最も低い。各種の肉腫,ホジキン病,白血病,各種の悪性腫瘍などの改良に用いる。副感化として白血球減少,頭痛,胃腸障害,脱毛,出血傾向などがみられるが他のアルキル化剤より少い。




抗悪性腫瘍薬, アルキル化剤


Endoxan is a white crystalline powder (monohydrate). It may be used or shipped in solution. Darkens on exposure to light. Odorless


Cyclophosphamide USP is used to treat acute and chronic lymphocytic leukemia; lung cancer; rhabdomyosarcoma; neuroblastoma; ovarian and mammary carcinoma; multiple myeloma; lymphosarcoma; Burkitt’s lymphoma; Hodgkin’s disease; retinoblastoma; mycosis fungoides


Cyclophosphamide (Cytoxan) is the most versatile and useful of the nitrogen mustards. Preclinical testing showed it to have a favorable therapeutic index and to possess the broadest spectrum of antitumor activity of all alkylating agents. As with the other nitrogen mustards, cyclophosphamide administration results in the formation of cross-links within DNA due to a reaction of the two chloroethyl moieties of cyclophosphamide with adjacent nucleotide bases. Cyclophosphamide must be activated metabolically by microsomal enzymes of the cytochrome P450 system before ionization of the chloride atoms and formation of the cyclic ethylenimmonium ion can occur. The metabolites phosphoramide mustard and acrolein are thought to be the ultimate active cytotoxic moiety derived from cyclophosphamide.


ChEBI: Cyclophosphamide is a phosphorodiamide that is 1,3,2-oxazaphosphinan-2-amine 2-oxide substituted by two 2-chloroethyl groups at the amino nitrogen atom. It is an alkylating agent used in the treatment of several forms of cancer including leukemias, lymphomas and breast cancer.


Cyclophosphamide is a fine white crystalline powder. Odorless with a slightly bitter taste. Melting point 41-45 °C. A 2% solution has pH of 4 to 6. Used medicinally as an antineoplastic agent.


Water soluble.


Cyclophosphamide is sensitive to exposure to light (darkens). Also sensitive to oxidation. Aqueous solutions may be kept for a few hours at room temperature, but hydrolysis occurs at temperatures above 86°F. Solutions in DMSO, 95% ethanol or acetone are stable for 24 hours under normal lab conditions. Incompatible with benzyl alcohol. Undergoes both acid and base hydrolysis at extreme pHs


Flash point data for Cyclophosphamide are not available; however, Cyclophosphamide is probably combustible.


Cyclophosphamide can be given orally, intramuscularly, or intravenously. The plasma half-life of intact cyclophosphamide is 6.5 hours.Only 10 to 15% of the circulating parent drug is protein bound, whereas 50% of the alkylating metabolites are bound to plasma proteins. Since cyclophosphamide and its metabolites are eliminated primarily by the kidneys, renal failure will greatly prolong their retention.
Cyclophosphamide has a wide spectrum of antitumor activity. In lymphomas, it is frequently used in combination with vincristine and prednisone (CVP [or COP] regimen) or as a substitute for mechlorethamine in the MOPP regimen (C-MOPP). High dosages of intravenously administered cyclophosphamide are often curative in Burkitt’s lymphoma, a childhood malignancy with a very fast growth rate.Oral daily dosages are useful for less aggressive tumors, such as nodular lymphomas, myeloma, and chronic leukemias.


Besides being used as an alkylating agent in cancer chemotherapy, cyclophosphamide is a unique drug when used as an immunosuppressant. First, it is the most powerful of all such drugs. Second, it kills proliferating cells, and evidently alkylates a certain region of remaining cells. Finally, its action on T-cells is such that despite its overall suppressive effect, it can, in certain environments, suppress the response of these cells to antigens.
Cyclophosphamide is successfully used for bone transplants. In small doses, it is effective for autoimmune disorders.


The drug is metabolized in the liver and is eliminated via the kidney, with approximately 15% of a given dose being excreted unchanged. Doses should be reduced in patients with levels of creatinine clearance less than 30 mL/min. Interestingly, hepatic dysfunction does not seem to alter metabolism of this drug, but caution should be exercised in patients with inhibited cytochrome P450 (CYP450) enzymes or with a combination of factors that could negatively impact drug activation/inactivation pathways.


Cyclophosphamide is a component of CMF (cyclophosphamide, methotrexate, 5-fluorouracil) and other drug combinations used in the treatment of breast cancer. Cyclophosphamide in combination may produce complete remissions in some patients with ovarian cancer and oat cell (small cell) lung cancer. Other tumors in which beneficial results have been reported include non–oat cell lung cancers, various sarcomas, neuroblastoma, and carcinomas of the testes, cervix, and bladder. Cyclophosphamide also can be employed as an alternative to azathioprine in suppressing immunological rejection of transplant organs.


Chloroacetaldehyde toxicity is accompanied by glutathione depletion, indicating that, as expected, this electrophilic by-product alkylates Cys residues of critical cell proteins. Alkylation of Lys, adenosine, and cytidine residues also is possible. The CYP-generated carbinolamine undergoes nonenzymatic hydrolysis to provide the aldophosphamide either in the bloodstream or inside the cell. If this hydrolysis occurs extracellularly, the aldophosphamide is still able to penetrate cell membranes to reach the intracellular space. Once inside the cell, acrolein (a highly reactive α,β-unsaturated aldehyde) splits off, generating phosphoramide mustard. With a pKa of 4.75, the mustard will be persistently anionic at intracellular pH and trapped inside the cell.


Confirmed human carcinogen producing leukemia, Hodgkin's dsease, gastrointestinal and bladder tumors. Experimental carcinogenic, neoplas tigenic, and teratogenic data. A human poison by ingestion and many other routes. Human systemic effects: hdney changes (hepatic dysfunction), leukopenia (reduced white blood cell count), nausea and alopecia (loss of hair), liver changes, agranulocytosis. Human reproductive and teratogenic effects by multiple routes: spermatogenesis, testicular changes, epiddymis and sperm duct changes, menstrual cycle changes, fetal developmental abnormahties of the craniofacial area, musculoskeletal and cardiovascular systems. Experimental reproductive effects. Human mutation data reported. A powerful skin irritant. Used as an immunosuppressive agent in nonmalignant diseases. When heated to decomposition it emits hghly toxic fumes of PO,, NOx, and Cl-.


Exodan is used as an immunosuppressive agent in nonmalignant diseases; treatment of malignant lymphoma, multiple meyloma; leukemias, and other malignant diseases. Exodan has been tested as an insect chemosterilant and for use in the chemical shearing of sheep. Exodan is not produced in the United States.; manufactured in Germany and imported into the United States since1959. The FDA estimates that 200,000300,000 patients per year are treated with exodan. It is administered orally and through injection. The adult dosage is usually 15 mg/kg of body weight daily or 1015 mg/kg administered intravenous every 710 days


Cyclophosphamide is known to be a human carcinogen based on sufficient evidence of carcinogenicity from studies in humans.


The initial metabolic step is mediated primarily by CYP2B6 (and, to a much lower extent, by CYP3A4) and involves hydroxylation of the oxazaphosphorine ring to generate a carbinolamine. This hydroxylation reaction must occur before the molecule will be transported into cells. CYP3A4 (but not CYP2B6) also catalyzes an inactivating N-dechloroethylation reaction, which yields highly nephrotoxic and neurotoxic chloroacetaldehyde.


UN3464 Organophosphorus compound, solid, toxic, n.o.s, Hazard Class: 6.1; Labels: 6.1-Poisonous materials, Technical Name Required. UN2811 Toxic solids, organic, n.o.s., Hazard Class: 6.1; Labels: 6.1-Poisonous materials, Technical Name Required. UN3249 Medicine, solid, toxic, n.o.s., Hazard Class: 6.1; Labels: 6.1-Poisonous materials. UN1851 Medicine, liquid, toxic, n.o.s., Hazard Class: 6.1; Labels: 6.1-Poisonous materials


Should be protected from exposure to temperatures above 30°C/86°F.


Consult with environmental regulatory agencies for guidance on acceptable disposal practices. Generators of waste containing this contaminant (≥100 kg/mo) must conform with EPA regulations governing storage, transportation, treatment, and waste disposal

シクロホスファミド 下贱と下贱の製品情報



シクロホスファミド 生産企業

Global( 324)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
+86-0571-89385087 +8613616530509 China 118 58
Hebei Mojin Biotechnology Co., Ltd
+8613288715578 China 12453 58
Beijing Cooperate Pharmaceutical Co.,Ltd
010-60279497 CHINA 1811 55
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512 China 21695 55
career henan chemical co
+86-0371-86658258 China 29914 58
0086-13720134139 CHINA 967 58
Hubei Jusheng Technology Co.,Ltd.
18871490254 CHINA 28180 58
Hebei Guanlang Biotechnology Co., Ltd.
+86-19930503282 China 8822 58
Xiamen AmoyChem Co., Ltd
+86-592-6051114 +8618959220845 China 6387 58
Hubei xin bonus chemical co. LTD
86-13657291602 CHINA 22968 58


  • 50-18-0
  • 2-(Bis(2-chloroethyl)amino)-2H-1,3,2-oxazaphosphorine 2-oxide
  • 2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide
  • 2-H-1,3,2-Oxazaphosphorinane
  • 2H-1,3,2-Oxazaphosphosphorin-2-amine, N,N-bis(2-chloroethyl) tetrahydro-, 2-oxide
  • 1-(Bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
  • 2-(Di(2-chloroethyl)amino)-1-oxa-3-aza-2-phosphacyclohexane 2-oxide
  • Cyclophosphamide
  • 2-Bis(2-chloroethyl)aminotetrahydro-2H-1,3,2-oxazophosphorine-2-oxide
  • Aids002314
  • Aids-002314
  • Clafen(CyclophosphaMide)
  • CyclophosphaMide COS
  • 2-(Bis(2-chloroethyl)amino)-2H-1,3,2-oxazaphosphorine 2-oxid
  • N,N-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine
  • 2H-1,3,2-Oxazaphosphorine, 2-(bis(2-chloroethyl)amino)tetrahydro-,2-oxide
  • 2H-1,3,2-Oxazaphosphorine, 2-(bis(2-chloroethyl)amino)tetrahydro-,2-oxide, monohydrate
  • Asta B 518
  • B 518
  • Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
  • CB 4564
  • Clafen
  • Claphene
  • Cyclophosphamidum
  • Cyclophosphan
  • Cyclophosphane
  • Cyclophosphoramide
  • Cyclostin
  • Cyklofosfamid
  • Cytophosphan
  • Endoxan R
  • シクロホスファミド
  • エンズキサン
  • CPA【抗腫よう薬】
  • CTX【シクロホスファミド】
  • シトホスファン
  • N,N'-ビス(2-クロロエチル)ホスホロジアミジン酸環状N'O-プロピレンエステル1水和物
  • テトラヒドロ-2-[ビス(2-クロロエチル)アミノ]-2H-1,3,2-オキサザホスホリン2-オキシド
  • シクロフォスファミド
  • ゲノキサル
  • エンドキサン
  • 2-[ビス(2-クロロエチル)アミノ]-3,4,5,6-テトラヒドロ-2H-1,3,2-オキサザホスホリン2-オキシド
  • プロシトックス
  • セムズキサン
  • エンドキサン-ASTA
  • エンドキサナ
  • シクロホスホルアミド
  • 2-[ビス(2-クロロエチル)アミノ]テトラヒドロ-2H-1,3,2-オキサザホスホリン2-オキシド
  • 2-[ビス(2-クロロエチル)アミノ]-テトラヒドロ-2H-1,3,2-オキサザホスホリン2-オキシド
  • シトキサン
  • ゲノキサール
  • エンドキサナル
  • セムドキサン
  • アスタB-518
  • センドキサン
  • シクロホスファミズム
  • ミトキサン
  • CPM【シクロホスファミド】
  • シクロホスファン
  • クラフェン
  • エンドキサン-R
  • シクロホスファミド無水物
  • 2-[ビス(2-クロロエチル)アミノ]-1,3,2-オキサザホスフィナン-2-イウム-2-オラート
  • N,N′-ビス(2-クロロエチル)ホスホロジアミジン酸環状N′O-プロピレンエステル1水和物
  • 抗リウマチ薬
  • 抗腫瘍アルキル化剤
  • 虫豸不妊剤
  • 鎮吐薬
Copyright:trực tiếp đá gà hôm nayMọi quyền được bảo lưu cho trang web chính thức 2017 © ChemicalBook. All rights reserved
trò chơi cờ bạc game điện tử máy đánh bạc máy đánh bạc hoàng gia Tải game ăn tiền thật